Skip to main content

Want a detailed portfolio tracker?

Performance analysis of BioAffinity Technologies (BIAF)

Annual Return

Over the past 3 years, BIAF has had an average annual return of -68.62%, underperforming the benchmark SPY, which returned +22.45% annual.

Since Sep 1, 2022, BIAF has had an average annual return of -73.52%, underperforming the benchmark SPY, which returned +20.30% annual.

20262025202420232022
+44.68%-95.71%-38.15%-8.09%-80.72%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026-2.13%-6.52%+258.14%-35.06%-33.00%+1.49%+44.68%
2025-16.42%-34.28%-48.01%+80.83%-40.46%+2.67%+10.40%-23.56%-59.25%-17.65%-38.78%-21.67%-95.71%
2024+6.77%+47.73%-12.92%+21.28%-2.03%-10.03%+15.30%-39.77%+38.68%-31.25%-15.03%-25.14%-38.15%
2023+63.12%-34.88%+11.18%+3.16%-6.13%-0%-3.85%-1.70%-32.73%+8.42%+31.58%-11.40%-8.09%
2022-64.94%-2.05%-5.27%-40.73%-80.72%

Drawdown analysis of BioAffinity Technologies (BIAF)

The maximum drawdown for the BIAF was -99.70%, occurring on Feb 5, 2026. This drawdown has not yet recovered.

The current BIAF drawdown is -99.32%.

Since Sep 1, 2022 BIAF has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-99.70%Sep 1, 2022859Feb 5, 2026OngoingOngoingOngoing